Personalizing Off-the-shelf, Systemic, Cancer Immunotherapy
GenVivo will make first- and best-in-class immune therapies that are immediately and easily deployable, highly effective, and which improve survival and quality of life beyond current therapies.
Creating innovative treatment options
Versatile Targeted, Non-Replicating Vector Platform
Our proprietary platform aims to set new standards in safety, efficacy, specificity of target and flexibility in mRNA payloads.
Retrovector - Labeled v3
Be part of the
GenVivo team
Our philosophy is to provide growth
opportunities and a comprehensive
compensation and benefits package to
support our most valued assets, our
employees.